These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 32774718)

  • 41. Modulation of Long Non-coding RNAs and MicroRNAs by Quercetin as a Potential Therapeutical Approach in Cancer: A Comprehensive Review.
    Asemi R; Mafi A; Sharifi M; Homayoonfal M; Davoodvandi A; Asemi Z
    Curr Med Chem; 2023 Oct; ():. PubMed ID: 37855340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization.
    Neaga A; Bagacean C; Tempescul A; Jimbu L; Mesaros O; Blag C; Tomuleasa C; Bocsan C; Gaman M; Zdrenghea M
    Front Immunol; 2020; 11():582915. PubMed ID: 33519805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting miRNAs by polyphenols: Novel therapeutic strategy for cancer.
    Pandima Devi K; Rajavel T; Daglia M; Nabavi SF; Bishayee A; Nabavi SM
    Semin Cancer Biol; 2017 Oct; 46():146-157. PubMed ID: 28185862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. microRNA-181 serves as a dual-role regulator in the development of human cancers.
    Rezaei T; Amini M; Hashemi ZS; Mansoori B; Rezaei S; Karami H; Mosafer J; Mokhtarzadeh A; Baradaran B
    Free Radic Biol Med; 2020 May; 152():432-454. PubMed ID: 31899343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiRNA as potential biomarkers and therapeutic targets for gastric cancer.
    Shin VY; Chu KM
    World J Gastroenterol; 2014 Aug; 20(30):10432-9. PubMed ID: 25132759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oncogenic micro-RNAs and Renal Cell Carcinoma.
    Grange C; Collino F; Tapparo M; Camussi G
    Front Oncol; 2014; 4():49. PubMed ID: 24672771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance.
    Hashemi M; Hasani S; Hajimazdarany S; Mirmazloomi SR; Makvandy S; Zabihi A; Goldoost Y; Gholinia N; Kakavand A; Tavakolpournegari A; Salimimoghadam S; Nabavi N; Zarrabi A; Taheriazam A; Entezari M; Hushmandi K
    Int J Biol Macromol; 2022 Dec; 222(Pt A):1151-1167. PubMed ID: 36191781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks.
    Shirafkan N; Mansoori B; Mohammadi A; Shomali N; Ghasbi M; Baradaran B
    Biomed Pharmacother; 2018 Jan; 97():1319-1330. PubMed ID: 29156521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of miRNA in cancer diagnosis, prognosis, therapy and regulation of its expression by Epstein-Barr virus and human papillomaviruses: With special reference to oral cancer.
    Chawla JP; Iyer N; Soodan KS; Sharma A; Khurana SK; Priyadarshni P
    Oral Oncol; 2015 Aug; 51(8):731-7. PubMed ID: 26093389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of microRNAs in the pathogenesis and treatment of hematopoietic malignancies.
    Schmid CA; Craig VJ; Müller A; Flori M
    Curr Pharm Des; 2013; 19(7):1201-10. PubMed ID: 23092340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives.
    Díaz-López A; Moreno-Bueno G; Cano A
    Cancer Manag Res; 2014; 6():205-16. PubMed ID: 24812525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNAs and Long Non-coding RNAs in c-Met-Regulated Cancers.
    Zhan H; Tu S; Zhang F; Shao A; Lin J
    Front Cell Dev Biol; 2020; 8():145. PubMed ID: 32219093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
    Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
    Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
    Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
    ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of microprocessor-dependent cancer cells allows screening for growth-sustaining micro-RNAs.
    Peric D; Chvalova K; Rousselet G
    Oncogene; 2012 Apr; 31(16):2039-48. PubMed ID: 21909134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulating miRNA by natural agents as a new strategy for cancer treatment.
    Sethi S; Li Y; Sarkar FH
    Curr Drug Targets; 2013 Sep; 14(10):1167-74. PubMed ID: 23834152
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA: potential targets for the development of novel drugs?
    Wu W
    Drugs R D; 2010; 10(1):1-8. PubMed ID: 20509710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complex interactions between microRNAs and hepatitis B/C viruses.
    Fan HX; Tang H
    World J Gastroenterol; 2014 Oct; 20(37):13477-92. PubMed ID: 25309078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA's - The vibrant performers in the oral cancer scenario.
    Solomon MC; Radhakrishnan RA
    Jpn Dent Sci Rev; 2020 Nov; 56(1):85-89. PubMed ID: 32612717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of MicroRNAs as Potential Therapeutics against Cancer.
    Abd-Aziz N; Kamaruzman NI; Poh CL
    J Oncol; 2020; 2020():8029721. PubMed ID: 32733559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.